On September 4, 2025, Ginkgo Bioworks Holdings, Inc. entered into a Sales Agreement allowing them to sell up to $100 million of Class A common stock through Allen & Company LLC. This agreement permits the sale of shares in at-the-market offerings as part of general corporate purposes.